To test whether SARA played a causal role in skin carcinogenesis, SARA mutant and WT mice were challenged using a two-stage chemically induced carcinogenesis protocol with DMBA as the initiator, followed by twice weekly treatments with the tumor promoter TPA. This evidence concerns the gene ZFYVE9 and neoplasm.